The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Authors:
Open Access
- 1 September 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (5) , 1720-1727
Abstract
A recombinant, truncated HSV type 1 glycoprotein D secreted by Chinese hamster ovary cells (rgD1) was used to compare the ability of several adjuvants to stimulate protective immunity in guinea pigs. Adjuvants tested included CFA, aluminum hydroxide (alum), a lipophilic derivative of muramyl tripeptide (MTP-PE), and a muramyl dipeptide (MDP) covalently conjugated to rgD1. Animals were immunized three times with rgD1 plus the various adjuvants and antibody titers were determined by ELISA. Four weeks after the last immunization, the animals were challenged intravaginally with HSV type 2 and were monitored daily for clinical signs of disease, including frequency and severity of herpetic lesions, incidence of urinary retention, and mortality during the 14-day post-challenge observation period. Animals immunized in the foot-pad with rgD1 formulated with CFA showed the highest antibody titers. Animals immunized in the footpad with rgD1 using MTP-PE in a 4% squalene formulation, alum, or rgD1 conjugated to MDP showed mean antibody titers that were 57, 16, and 13% of the CFA titers, respectively. Immunization with rgD1 plus MTP-PE, alum, or rgD1-MDP conjugate by the i.m. route elicited lower antibody titers than the footpad route of immunization. Results of the viral challenge indicated that clinical symptoms of the groups immunized with rgD1 with CFA or MTP-PE as adjuvant were similar in magnitude and were markedly reduced compared with unimmunized control groups. Animals immunized with rgD1 combined with alum or rgD1-MDP conjugate showed clinical symptoms significantly more severe than the CFA or MTP-PE groups. The protective immunity observed after i.m. immunization of animals with rgD1 and MTP-PE was only slightly lower than animals immunized with the same Ag-adjuvant combination in the footpad. The results indicate that MTP-PE is an effective adjuvant for the recombinant herpes gD vaccine.Keywords
This publication has 34 references indexed in Scilit:
- Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological diseaseInfection and Immunity, 1981
- Cell-mediated immunity to herpes simplex virus: induction of cytotoxic T lymphocyte responses by viral antigens incorporated into liposomes.The Journal of Immunology, 1981
- Mechanism of Recovery from Systemic Herpes Simplex Virus Infection. I. Comparative Effectiveness of Antibody and Reconstitution of Immune Spleen Cells on Immunosuppressed MiceThe Journal of Infectious Diseases, 1980
- COMPARATIVE SELECTIVITY OF ADJUVANTS FOR HUMORAL AND CELL-MEDIATED-IMMUNITY .2. EFFECT ON DELAYED-TYPE HYPERSENSITIVITY IN THE MOUSE AND GUINEA-PIG, AND CELL-MEDIATED-IMMUNITY TO TUMOR-ANTIGENS IN THE MOUSE OF FREUNDS INCOMPLETE AND COMPLETE ADJUVANTS, ALHYDROGEL, CORYNEBACTERIUM-PARVUM, BORDETELLA-PERTUSSIS, MURAMYL DIPEPTIDE AND SAPONIN1980
- Cellular and Humoral Immunity in Guinea Pigs to Two Major Polypeptides Derived from Hepatitis B Surface AntigenJournal of General Virology, 1978
- Control of Influenza and Poliomyelitis with Killed Virus VaccinesScience, 1977
- Dose-Response Relationship after Immunization of Volunteers with a New, Surface-Antigen-Adsorbed Influenza Virus VaccineThe Journal of Infectious Diseases, 1977
- LACK OF ADJUVANT EFFECT OF ALPO4 ON PURIFIED INFLUENZA VIRUS HEMAGGLUTININS IN MAN1968
- FURTHER INVESTIGATIONS ON THE IMMUNOGENIC ACTIVITY OF AQUEOUS AND ALUMINUM OXIDE ADSORBED INACTIVATED POLIOVIRUS VACCINES IN MACACA MULATTA1American Journal of Epidemiology, 1967
- PRESENT STATUS OF FIELD AND LABORATORY STUDIES OF TYPHOID AND PARATYPHOID VACCINES - WITH SPECIAL REFERENCE TO STUDIES SPONSORED BY WORLD HEALTH ORGANIZATION1965